CV Sciences (CVSI) Common Equity (2010 - 2026)
CV Sciences (CVSI) posted Common Equity of $1.5 million for Q1 2026, up 2.04% sequentially from $1.5 million in Q4 2025, and down 20.82% YoY from $1.9 million in Q1 2025.
CV Sciences (CVSI) Common Equity (2010 - 2026) Analysis & Trends
CV Sciences has reported Common Equity for 17 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Common Equity fell 20.82% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 20.82% YoY) and the FY2025 annual result came in at $1.5 million, down 18.22% from the prior year.
- Common Equity grew to $1.5 million in Q1 2026 per CVSI's latest filing, from $1.5 million in the prior quarter.
- Over five years, Common Equity peaked at $5.0 million in Q1 2023 and troughed at -$777000.0 in Q4 2022.
- A 5-year average of $2.3 million and a median of $1.9 million in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 121.93% in 2022, then surged 473.62% in 2023.
- Over 5 years, Common Equity stood at -$777000.0 in 2022, then soared by 473.62% to $2.9 million in 2023, then tumbled by 38.17% to $1.8 million in 2024, then dropped by 18.22% to $1.5 million in 2025, then rose by 2.04% to $1.5 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $1.5 million, $1.5 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 3.89 Mn |
| Mar 31, 2023 | 5.05 Mn |
| Dec 31, 2022 | -777,000.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 3.54 Mn |
| Sep 30, 2021 | 11.14 Mn |